Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lila

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Terapevticheskii Arkhiv|June 30, 2020
[The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
Terapevticheskii Arkhiv|April 16, 2025
[Experience with the use of undenatured type II collagen in patients with stage III knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
Terapevticheskii Arkhiv|June 3, 2024
[Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
The New England Journal of Medicine|February 10, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard A Furie, Brad H Rovin, Jay P Garg, et al.
Terapevticheskii Arkhiv|February 1, 2019
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)A E Karateev, E Yu Pogozheva, E A Filatova, et al.
Doklady. Biochemistry and Biophysics|August 28, 2024
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLARV I Mazurov, E L Nasonov, A M Lila, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians]V I Simanenkov, I V Maev, O N Tkacheva, et al.
Terapevticheskii Arkhiv|April 16, 2025
[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases]G V Lukina, O V Knyazev, E A Belousova, et al.
Doklady. Biochemistry and Biophysics|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Terapevticheskii Arkhiv|June 30, 2020
[The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
Terapevticheskii Arkhiv|April 16, 2025
[Experience with the use of undenatured type II collagen in patients with stage III knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
Terapevticheskii Arkhiv|June 3, 2024
[Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial]L I Alekseeva, N G Kashevarova, E A Taskina, et al.
The New England Journal of Medicine|February 10, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard A Furie, Brad H Rovin, Jay P Garg, et al.
Terapevticheskii Arkhiv|February 1, 2019
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)A E Karateev, E Yu Pogozheva, E A Filatova, et al.
Doklady. Biochemistry and Biophysics|August 28, 2024
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLARV I Mazurov, E L Nasonov, A M Lila, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians]V I Simanenkov, I V Maev, O N Tkacheva, et al.
Terapevticheskii Arkhiv|April 16, 2025
[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases]G V Lukina, O V Knyazev, E A Belousova, et al.
Doklady. Biochemistry and Biophysics|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTAE L Nasonov, V I Mazurov, A M Lila, et al.
Pageof 6